Pharmacists in Morristown, New Jersey


45 Pharmacists found in Morristown
female pharmacist

Dr. Ramya Kambhampati, PHARM D


Pharmacist
95 Madison Ave Ste 110, Morristown, NJ 07960
973-998-0287     973-998-0288

male pharmacist

Mr. Raymond Rapkin, RPH


Pharmacist
60 South St, Morristown, NJ 07960
973-538-1023    

female pharmacist

Rena Blau


Pharmacist
203 South St, Morristown, NJ 07960
973-889-8901    



male pharmacist

Mr. Robert Fazzini


Pharmacist
60 South St, Morristown, NJ 07960
973-538-1023    

female pharmacist

Roshni Desai


Pharmacist
203 South St, Morristown, NJ 07960
973-889-8901    

female pharmacist

Roxanna Monshi, PHARMD


Pharmacist
209 South Street, Morristown, NJ 07960
973-889-8901    

female pharmacist

Sarah Sweet


Pharmacist
203 South St, Morristown, NJ 07960
973-889-8901    

male pharmacist

Scott Collins, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
100 Madison Ave, Morristown, NJ 07960
973-682-2100    

male pharmacist

Dr. Scott Peter Angus, PHARM.D.


Pharmacist
22 South St, Morristown, NJ 07960
973-656-0011    

female pharmacist

Sonia Soin


Pharmacist
7 Hamilton Rd Apt 2n, Morristown, NJ 07960
516-592-2526    

female pharmacist

Dr. Stacy Mcdonough Hardeo, PHARMD, BCPS


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
100 Madison Ave, Box 80, Morristown, NJ 07960
973-971-5000    

female pharmacist

Susan Novembre


Pharmacist
213 South St, Morristown, NJ 07960
973-540-9599    

male pharmacist

Dr. Trevor John Silbernagel, PHARMD


Pharmacist
100 Madison Ave, Morristown, NJ 07960
973-971-5000    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.